|Articles|August 4, 2011

Hormone Therapy Guidelines

Discover effective strategies and insights to navigate menopause, enhancing well-being and embracing this transformative life stage.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

ByJoyce Slingerland, MD, PhD

December 9th 2025

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

ByGenevieve Neal-Perry, MD, PhD

December 8th 2025

Contemporary OB/GYN week in review: Cendifensine, weight gain, and more

ByCeleste Krewson, Assistant Editor

December 5th 2025

Rebecca Dunsmoor-Su, MD, highlights reduced hot flashes from cendifensine

ByRebecca Dunsmoor-Su, MD

December 4th 2025

Contemporary OB/GYN week in review: Sleep education, AI in IVF, and more

ByCeleste Krewson, Assistant Editor

November 28th 2025

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Hormone Therapy Guidelines

Newsletter

Related Content

Joyce Slingerland, MD, PhD, notes how estrone and obesity impact breast cancer risk postmenopause

Genevieve Neal-Perry, MD, PhD, discusses new nonhormonal treatments for hot flashes

Contemporary OB/GYN week in review: Cendifensine, weight gain, and more

Rebecca Dunsmoor-Su, MD, highlights reduced hot flashes from cendifensine

Contemporary OB/GYN week in review: Sleep education, AI in IVF, and more

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

High costs and transfusions linked to acute heavy menstrual bleeding

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more